CLBE: Financials Out!!! Profitable!!
BIOLOGY & MEDICINE
The Case for Adult Stem Cell Research
these individuals are all part of Calbatech
Kary Mullis, Ph.D. :: Nobel Laureate
Ph.D. Biochemistry, UC Berkeley
Dr. Mullis received the Nobel Prize in chemistry in 1993, for his invention of the polymerase chain reaction (PCR). The process, which Dr. Mullis conceptualized in 1983, is hailed as one of the monumental scientific techniques of the 20th century, one that revolutionized genetic science and engineering. PCR has also been an enormous commercial success. The original patent was sold to Hoffman LaRoche for $300 million and has generated more than a billion dollars in revenue from royalties.
Paul Heaney, Ph.D.
Ph.D. Medicinal Chemistry, Univ. of Glascow, Scotland
Dr. Heaney has held numerous positions within the life sciences industry, most recently as EVP of Research and Technology at Sequenom. Dr. Heaney's team was responsible for the development of the highly acclaimed and commercially successful chip-based MassARRAY™ Genotyping Platform and the MassARRAY™ 200K which can be multiplexed to more than one million DNA assays per day. While Head of Bioelectronics at the Sarnoff Corporation, Dr. Heaney's team was awarded a $12 million DARPA grant which led to the spin-out of Orchid BioSciences. Dr. Heaney holds more than 25 patents.
< Top of Page
David O'Bryan, Ph.D.
Ph.D. Medical Sciences/Biochemistry, BU Med School
Dr. O'Bryan is a former Senior VP at SmithKline Beecham Clinical Laboratories. He has more than 28 years experience in the clinical testing industry, including significant experience in developing new technologies. On behalf of SmithKline Beecham Clinical Laboratories he negotiated license agreements involving patented gene sequences used to diagnose diseases and secured the first license for nucleic acid testing. Dr. O'Bryan is also a recognized expert in laboratory instrumentation and automation in the commercial reference laboratory industry.
< Top of Page
Gerald Huth, Ph.D.
Ph.D. Physics/Electronics, Uppsala University, Sweden
In 1985, Dr. Huth founded Xsirius Scientific, Inc. Two subsidiaries, Xsirius Superconductivity, Inc. and Xsirius Photonics, Inc. had IPOs and traded on NASDAQ, with Xsirius Scientific having a market cap exceeding $100 million.To learn more about Dr. Huth and his inventions visit www.ghuth.com
< Top of Page
Jason Van Tassel, M.D.
Dr. Van Tassel is currently in medical practice specializing in Otolaryngology, Facial Plastic and Reconstructive Surgery in Los Angeles, CA. Dr. Van Tassel attended Georgetown University School of Medicine in Washington D.C., graduating with Honors in 1997. Upon completion of his residency, Dr. Van Tassel joined the faculty at the University of California at Irvine in the Department of Facial Plastic and Reconstructive Surgery, completing a fellowship in 2003. He is currently board certified in Otolaryngology and board eligible in Facial Plastic and Reconstructive Surgery. Prior to practicing medicine in LA, Dr. Van Tassel worked at Hybritech Inc., where he performed research investigating manufacturing processes related to monoclonal antibody test assays. In addition, Dr. Van Tassel also investigated retinal signal transduction pathways for the Dept. of Neurosciences at San Diego State.